as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹890.4
Change
-13.4 (-1.48%)
Open
₹903.8
Prev. Close
₹903.8
Day High
₹905.0
Day Low
₹885.85
Volume Analysis
Traded
10,691
Delivered
5,584
Delivery %
52.23%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (2)
- •Strong return on equity (25.1%)
- •Strong operating margin (23.0%)
Weaknesses (0)
No signal for this stock
Opportunities (3)
- •Strong 3-year EPS growth (60.6%)
- •Strong 3-year revenue growth (52.1%)
- •FII holding has been rising
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹920.8 | ₹912.9 | ₹901.65 | ₹893.75 | ₹882.5 | ₹874.6 | ₹863.35 |
| Fibonacci | ₹912.9 | ₹905.58 | ₹901.07 | ₹893.75 | ₹886.43 | ₹881.92 | ₹874.6 |
| Camarilla | ₹895.67 | ₹893.91 | ₹892.16 | ₹893.75 | ₹888.64 | ₹886.89 | ₹885.13 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
—
1 Week
-2.62%
1 Month
+0.01%
3 Months
-11.2%
6 Months
-2.51%
1 Year
—
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹173.58
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
24.05%
Net margin 18.78% × asset turnover 0.97x × equity multiplier 1.32x
Company Overview
Sector
Capital Goods
Market Cap
₹1,945 Cr
P/E (TTM)
56.6
ROE
25.1%
Book Value
₹77.9
Face Value
₹2.0
Source: Screener.in (Consolidated figures) — data as of 15 Nov 2026. Not investment advice.
TopFund Analysis
Sika Interplant Systems L holds up reasonably well on TopFund's composite fundamentals check within the Capital Goods sector, at 69/100. The strongest factor is Financial Strength (100/100), while Valuation (1/100) is the weakest area to weigh before deciding. Notably: Strong return on equity (25.1%); strong operating margin (23.0%). Strong 3-year EPS growth (60.6%).
TopFund Score — Fundamentals Quality
69/100 — GoodData confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company is almost debt free.
- +Company has delivered good profit growth of 24.6% CAGR over last 5 years
- +Company has been maintaining a healthy dividend payout of 20.8%
- +Debtor days have improved from 45.4 to 18.3 days.
- −Stock is trading at 11.8 times its book value
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Submitted Regulation 74(5) certificate for 1 Oct-31 Oct 2026; no demat or remat requests received.
Reg. 74(5) certificate confirms no dematerialisation or rematerialisation requests during 1-30 September 2026.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 18 | 26 | 37 | 30 | 33 | 38 | 46 | 68 | 52 | 50 | 41 | 43 | 46 |
| Expenses + | 14 | 21 | 31 | 24 | 26 | 30 | 38 | 56 | 41 | 39 | 31 | 35 | 36 |
| Operating Profit | 4 | 5 | 7 | 6 | 7 | 8 | 8 | 13 | 11 | 12 | 10 | 8 | 10 |
| OPM % | 21.14% | 20.69% | 17.73% | 20.22% | 20.7% | 20.62% | 17.3% | 18.38% | 20.63% | 23.06% | 25.21% | 19.48% | 22.53% |
| Other Income + | 3 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 0 | 3 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 7 | 6 | 8 | 7 | 8 | 9 | 10 | 14 | 12 | 13 | 10 | 10 | 11 |
| Tax % | 25.19% | 25.32% | 19.97% | 25.25% | 21.45% | 19.14% | 19.06% | 25.2% | 23.81% | 25.14% | 25.31% | 18.68% | 24.93% |
| Net Profit + | 5 | 5 | 6 | 5 | 6 | 7 | 8 | 10 | 9 | 9 | 8 | 8 | 9 |
| EPS in Rs | 2 | 2 | 3 | 2 | 3 | 3 | 4 | 5 | 4 | 4 | 4 | 4 | 4 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | 37 | 77 | 97 | 24 | 82 | 46 | 24 | 124 | 55 | 32 | -10 | -37 | -10 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 30 | 42 | 34 | 22 | 46 | 63 | 80 | 98 | 60 | 106 | 148 | 211 | 181 |
| Expenses + | 28 | 39 | 32 | 20 | 39 | 54 | 65 | 78 | 50 | 86 | 119 | 166 | 140 |
| Operating Profit | 2 | 3 | 3 | 2 | 6 | 9 | 15 | 20 | 10 | 20 | 29 | 45 | 41 |
| OPM % | 8.0% | 7.0% | 8.0% | 10.0% | 13.0% | 15.0% | 18.0% | 20.0% | 17.0% | 19.0% | 20.0% | 21.0% | 23.0% |
| Other Income + | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 7 | 6 | 5 | 6 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 2 | 3 | 3 | 2 | 6 | 9 | 16 | 22 | 12 | 25 | 33 | 49 | 45 |
| Tax % | 32.0% | 36.0% | 34.0% | 25.0% | 29.0% | 23.0% | 25.0% | 26.0% | 28.0% | 24.0% | 23.0% | 25.0% | — |
| Net Profit + | 2 | 2 | 2 | 1 | 4 | 7 | 12 | 17 | 9 | 19 | 25 | 36 | 34 |
| EPS in Rs | 1 | 1 | 1 | 1 | 2 | 3 | 6 | 8 | 4 | 9 | 12 | 17 | 16 |
| Dividend Payout % | 21.0% | 19.0% | 17.0% | 23.0% | 8.0% | 7.0% | 14.0% | 10.0% | 19.0% | 22.0% | 20.0% | 20.0% | — |
| Sales growth | 37 | 38 | -18 | -35 | 104 | 38 | 27 | 23 | -39 | 77 | 39 | 43 | -11 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 35 | 36 | 38 | 39 | 42 | 48 | 60 | 74 | 81 | 99 | 120 | 151 | 161 |
| Borrowings + | 3 | 3 | 2 | 3 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Other Liabilities + | 2 | 13 | 6 | 4 | 16 | 17 | 16 | 20 | 18 | 19 | 29 | 20 | 51 |
| Total Liabilities | 44 | 55 | 50 | 50 | 64 | 70 | 81 | 98 | 103 | 122 | 153 | 175 | 218 |
| Fixed Assets + | 34 | 35 | 37 | 37 | 37 | 37 | 37 | 36 | 36 | 43 | 45 | 44 | 43 |
| CWIP | 0 | 2 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1 | 0 | 3 | 3 | 8 | 19 | 2 | 9 | 20 | 30 | 38 | 81 | 82 |
| Other Assets + | 9 | 18 | 8 | 8 | 18 | 14 | 42 | 53 | 48 | 48 | 70 | 50 | 92 |
| Total Assets | 44 | 55 | 50 | 50 | 64 | 70 | 81 | 98 | 103 | 122 | 153 | 175 | 218 |
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 1 | 3 | 5 | 1 | 7 | 11 | 8 | 16 | -3 | 20 | 8 | 47 |
| Cash from Investing Activity + | -1 | -3 | -5 | 0 | -4 | -10 | -8 | -14 | 5 | -18 | -3 | -40 |
| Cash from Financing Activity + | -1 | 0 | 1 | -2 | -1 | -1 | -1 | -2 | -2 | -2 | -4 | -6 |
| Net Cash Flow | -2 | 1 | 0 | -1 | 2 | 0 | -1 | 0 | 0 | 0 | 0 | 2 |
| Free Cash Flow | 0 | 0 | 2 | 0 | 9 | 11 | 8 | 16 | -4 | 13 | 5 | 46 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 60 | 138 | 212 | 56 | 147 | 148 | 84 | 109 | 1 | 130 | 55 | 131 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 25.68% | 25.64% | 25.5% | 25.51% | 25.51% | 25.15% | 25.15% | 25.13% | 25.1% | 25.04% | 24.98% | 25.04% |
| Promoters | 71.72% | 71.72% | 71.72% | 71.72% | 71.72% | 71.72% | 71.72% | 71.72% | 71.72% | 71.72% | 71.72% | 71.72% |
| FII | 2.6% | 2.64% | 2.77% | 2.77% | 2.77% | 3.11% | 3.11% | 3.14% | 3.14% | 3.21% | 3.25% | 3.18% |
| DII | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.01% | 0.01% | 0.04% | 0.04% | 0.04% | 0.06% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Capital Goods — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Sika Interplant Systems L (this stock) | 1,945 | 56.6 | 11.77 | 25.1% |
| Jnk India Limited | 1,944 | 25.8 | 3.28 | 12.1% |
| Man Coat Metal & Ind Ltd | 1,920 | 42.2 | 4.49 | 11.0% |
| Krishna Def And Ald Ind L | 1,898 | 38.2 | 8.7 | 25.4% |
| Mukand Ltd. | 1,993 | 3.22 | 1.29 | 5.57% |
| Advait Enrgy Transition L | 2,011 | 30.2 | 6.58 | 20.4% |
| Exicom Tele Systems Ltd | 1,858 | — | 3.43 | -40.8% |
Which Mutual Funds Hold Sika Interplant Systems L?
Frequently Asked Questions about Sika Interplant Systems L
Sika Interplant Systems L (SIKA) closed at ₹890.4 on NSE on 19 November 2026, down 13.4 (1.48%) from the previous close.
Sika Interplant Systems L trades on the NSE (National Stock Exchange of India) under the symbol SIKA.
Sika Interplant Systems L has a trailing twelve-month P/E (price-to-earnings) ratio of 56.6.
Sika Interplant Systems L has a dividend yield of 0.38%.
Sika Interplant Systems L's 52-week high is ₹1,359.0 and its 52-week low is ₹755.0.
Sika Interplant Systems L has a market capitalisation of ₹1,945 crore.
Sika Interplant Systems L has a TopFund Quality Score of 69/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Sika Interplant Systems L?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.